XKRX:293480 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
11190.00
(-0.36%)
Sep 13
Business Description
Hana Pharm Co Ltd
ISIN : KR7293480000
Share Class Description:
XKRX:293480: Ordinary SharesCompare
Compare
Traded in other countries / regions
293480.Korea IPO Date
2018-10-02Description
Hana Pharm Co Ltd is a Korea based company engaged in drug development. It offers products for anesthetics, narcotic analgesics, antiemetics, antibiotics, dermatology, urinology, osteoporosis, and central nervous system.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.25 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | 1.09 | |||||
| Interest Coverage | 98.62 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 3.35 | |||||
| Beneish M-Score | -2.42 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 8.2 | |||||
| 3-Year EBITDA Growth Rate | 1.1 | |||||
| 3-Year EPS without NRI Growth Rate | 8.7 | |||||
| 3-Year Book Growth Rate | 6.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 12.88 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.36 | |||||
| 9-Day RSI | 39.71 | |||||
| 14-Day RSI | 38.55 | |||||
| 6-1 Month Momentum % | -13.83 | |||||
| 12-1 Month Momentum % | -16.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 1.58 | |||||
| Cash Ratio | 0.23 | |||||
| Days Inventory | 212.85 | |||||
| Days Sales Outstanding | 60.63 | |||||
| Days Payable | 33.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.56 | |||||
| Dividend Payout Ratio | 0.42 | |||||
| Forward Dividend Yield % | 4.56 | |||||
| 5-Year Yield-on-Cost % | 4.56 | |||||
| Shareholder Yield % | 5.98 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.51 | |||||
| Operating Margin % | 10.61 | |||||
| Net Margin % | 9.13 | |||||
| FCF Margin % | 3.51 | |||||
| ROE % | 7.42 | |||||
| ROA % | 5.82 | |||||
| ROIC % | 6.1 | |||||
| 3-Year ROIIC % | 3.66 | |||||
| ROC (Joel Greenblatt) % | 10.9 | |||||
| ROCE % | 7.73 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.48 | |||||
| Forward PE Ratio | 6.98 | |||||
| PE Ratio without NRI | 9.19 | |||||
| Price-to-Owner-Earnings | 132.79 | |||||
| PS Ratio | 0.87 | |||||
| PB Ratio | 0.69 | |||||
| Price-to-Tangible-Book | 0.73 | |||||
| Price-to-Free-Cash-Flow | 24.7 | |||||
| Price-to-Operating-Cash-Flow | 11.73 | |||||
| EV-to-EBIT | 9.5 | |||||
| EV-to-EBITDA | 7.1 | |||||
| EV-to-Revenue | 0.98 | |||||
| EV-to-FCF | 27.86 | |||||
| Price-to-Projected-FCF | 0.84 | |||||
| Price-to-Graham-Number | 0.55 | |||||
| Price-to-Net-Current-Asset-Value | 5.83 | |||||
| Earnings Yield (Greenblatt) % | 10.53 | |||||
| FCF Yield % | 4.05 | |||||
| Forward Rate of Return (Yacktman) % | -3.06 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hana Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 223,548.595 | ||
| EPS (TTM) (â‚©) | 1180 | ||
| Beta | 0.33 | ||
| Volatility % | 10.2 | ||
| 14-Day RSI | 38.55 | ||
| 14-Day ATR (â‚©) | 246.329672 | ||
| 20-Day SMA (â‚©) | 11432.5 | ||
| 12-1 Month Momentum % | -16.9 | ||
| 52-Week Range (â‚©) | 10790 - 14940 | ||
| Shares Outstanding (Mil) | 17.3 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hana Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hana Pharm Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hana Pharm Co Ltd Frequently Asked Questions
What is Hana Pharm Co Ltd(XKRX:293480)'s stock price today?
The current price of XKRX:293480 is â‚©11190.00. The 52 week high of XKRX:293480 is â‚©14940.00 and 52 week low is â‚©10790.00.
When is next earnings date of Hana Pharm Co Ltd(XKRX:293480)?
The next earnings date of Hana Pharm Co Ltd(XKRX:293480) is .
Does Hana Pharm Co Ltd(XKRX:293480) pay dividends? If so, how much?
The Dividend Yield %  of Hana Pharm Co Ltd(XKRX:293480) is 4.56% (As of Today), Highest Dividend Payout Ratio of Hana Pharm Co Ltd(XKRX:293480) was 0.44. The lowest was 0.14. And the median was 0.3. The  Forward Dividend Yield % of Hana Pharm Co Ltd(XKRX:293480) is 4.56%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers